Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data FULLER H B CO files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2025
FY2024
FY2025
Revenue
2,306
3,041
2,897
2,790
3,278
3,749
3,511
3,569
3,474
Cost of revenue
1,707
2,213
2,090
2,034
2,433
2,785
2,502
2,507
2,393
Gross profit
599
828
807
757
845
964
1,009
1,062
1,081
Selling, general and administrative
479
590
581
538
593
641
654
714
726
Operating income
120
238
226
218
253
323
355
348
Interest expense
43.7
111
103
86.8
78.1
91.5
135
133
133
Interest income
3.93
11.8
12.2
11.4
9.48
7.78
3.94
4.68
4.82
Other non-operating income
-0.61
-1.98
39.2
Pre-tax income
60.6
157
173
158
217
252
234
183
215
Income tax
9.81
-6.36
49.4
41.9
63
77.2
93.5
56.4
67.1
Net income to minority interests
0.05
0.02
0.03
0.07
0.08
0.09
0.08
0.14
0.14
0.11
Net income
59.4
171
131
124
161
180
145
130
130
152
EBITDA
207
383
367
357
396
470
515
523
EPS, basic
1.18
3.38
2.57
2.38
3.05
3.37
2.67
2.37
2.78
EPS, diluted
1.15
3.29
2.52
2.36
2.97
3.26
2.59
2.30
2.75
Shares, basic (weighted)
50.4
50.6
50.9
52
52.9
53.6
54.3
54.9
54.6
Shares, diluted (weighted)
51.6
52
52
52.5
54.3
55.3
56
56.6
55.4
Dividend per share
0.59
0.62
0.64
0.65
0.67
0.74
0.81
0.86
0.93
Balance sheet
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2025
FY2024
FY2025
Cash and equivalents
194
151
112
101
61.8
79.9
179
169
107
Receivables
474
495
493
515
615
607
578
558
564
Inventory
372
348
337
323
448
492
442
467
472
Other current assets
117
95.7
90.7
81.1
96.3
120
113
104
120
Total current assets
1,158
1,090
1,033
1,020
1,221
1,299
1,312
1,299
1,263
Property, plant and equipment
670
637
630
671
695
734
825
882
935
Lease right-of-use assets
0
28.4
32.7
32.4
47.4
61.1
55.7
Goodwill
1,337
1,305
1,282
1,312
1,299
1,393
1,487
1,532
1,680
Intangible assets
1,002
908
799
756
687
702
729
770
806
Other non-current assets
207
237
241
278
372
336
371
450
498
Total assets
4,373
4,176
3,986
4,037
4,275
4,464
4,724
4,933
5,183
Accounts payable
268
273
299
316
500
461
440
491
470
Accrued liabilities
84.2
75.8
60.7
84
86.1
89.3
108
97
134
Short-term debt
21.5
91.2
65
0
0
0
0
0
0
Total current liabilities
505
546
542
530
737
706
693
719
743
Long-term debt
2,399
2,142
1,898
1,757
1,591
1,736
1,837
2,010
2,017
Lease liabilities
24.1
23.4
36.9
48.6
42.5
Other non-current liabilities
346
265
242
279
277
358
388
322
368
Total liabilities
3,321
3,023
2,763
2,655
2,677
2,853
2,968
3,103
3,180
Total debt
2,420
2,233
1,963
1,757
1,591
1,736
1,837
2,010
2,017
Paid-in capital
74.7
95.9
130
158
214
266
301
323
298
Retained earnings
1,127
1,286
1,384
1,474
1,601
1,741
1,843
1,925
2,026
Other comprehensive income
-201
-280
-344
-303
-270
-451
-443
-473
-375
Shareholders' equity
1,051
1,153
1,222
1,381
1,597
1,610
1,755
1,829
2,003
Minority interests
0.39
0.4
0.44
0.54
0.59
0.62
0.71
1.19
-0.02
Total equity
1,052
1,152
1,223
1,597
1,597
1,611
1,756
1,830
2,003
Total liabilities and equity
4,373
4,176
3,986
4,037
4,275
4,464
4,724
4,933
5,183
Shares outstanding
50.4
50.7
51.2
51.9
52.8
53.7
54.1
54.7
54.2
Cash flow statement
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2025
FY2024
FY2025
Net income
59.5
171
131
124
161
180
145
130
130
152
Depreciation and amortization
87.3
145
141
139
143
147
160
175
178
Stock-based compensation
17.5
17.1
24
16.9
22.4
24.4
19.9
21.9
22.1
Deferred income tax
-20.2
-55.6
-10.9
-21.2
-7.34
-2.13
-17.8
-54.6
-40.6
Change in receivables
-26.8
-39.4
-25.6
-14.8
-125
-24.8
68.7
10.7
-3.44
Change in inventory
-8.66
-17.1
19.6
15.7
-135
-55.8
72.6
-30.1
-10.3
Cash from operations
166
253
269
332
213
257
378
302
263
Capital expenditures
-54.9
-68.3
-62
-87.3
-96.1
-130
-119
-139
-142
Acquisitions
-1,745
3.5
-8.29
-9.5
-5.45
-251
-205
-274
-167
Purchases of investments
-1.25
0
0
-2.55
Cash from investing
-1,801
-61.8
7.41
-109
-94.7
-375
-319
-407
-232
Debt issued
2,856
0
0
300
0
335
2,233
1,933
1,300
Debt repaid
-1,079
-186
-289
-518
-157
-160
-2,126
-1,765
-1,305
Stock issued
17.7
6.24
10.9
12.3
32.3
30.1
14.6
35.9
9.85
Share buybacks
-21.8
-4.69
-3.03
-3.43
-2.68
-3.95
-2.57
-39.6
-60.7
Dividends paid
-29.6
-31.1
-32.4
-33.5
-34.9
-39.2
-43.4
-47.6
-50.3
Cash from financing
1,685
-229
-315
-239
-154
160
35.1
112
-108
Net change in cash
52.2
-43.6
-38.6
-11.7
-38.7
18.1
99.5
-10.1
-62.1
Free cash flow
111
185
207
244
117
127
259
163
121
Interest paid
43.8
109
107
69.5
62.8
83.5
137
135
133
Income taxes paid
38
36.8
37.2
50
73
73.4
71.3
123
125
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to August 29, 2026; growth uses fiscal years. Valuation uses the share price of $50.06 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
32.3%
Gross profit / revenue.
Pre-tax margin
7.4%
Pre-tax income / revenue.
Net margin
5.6%
Net income / revenue.
FCF margin
2.8%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
8.1%
Cash from operations / revenue.
Effective tax rate
26.6%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
9.1%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
3.6%
Net income / average total assets.
SG&A / revenue
21.6%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.7%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
5.3%
Capital expenditures / revenue.
D&A / revenue
5.2%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-2.7%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
1.8%
Gross profit vs the same period a year earlier. Only from a positive base.
Net income growth, 1y
16.7%
Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
19.6%
EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
-12.9%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y
-25.7%
Free cash flow vs the same period a year earlier. Only from a positive base.
Dividend per share growth, 1y
8.4%
Dividend per share vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
9.5%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
5.1%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
-2.2%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.82x
Current assets / current liabilities.
Quick ratio
0.91x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.12x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.95x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
37.9%
Total debt / total assets.
Liabilities / assets
60.1%
Total liabilities / total assets.
Net debt
$1.96B
Total debt - cash - short-term investments. Negative means more cash than debt.
Days inventory + days sales outstanding - days payables.
FCF conversion
50.6%
Free cash flow / net income, when net income is positive.
Capex / operating cash flow
65.4%
Capital expenditures / cash from operations, when that is positive.
Per share
Metric
Value
How it is calculated
EPS, diluted
$3.60
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$64.73
Revenue / diluted weighted shares.
FCF per share
$1.82
Free cash flow / diluted weighted shares.
Operating cash flow per share
$5.27
Cash from operations / diluted weighted shares.
Book value per share
$40.28
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Dividends paid / net income, when net income is positive.
Dividends / FCF
51.8%
Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF
48.8%
Share buybacks / free cash flow, when free cash flow is positive.
Valuation
Metric
Value
How it is calculated
Market cap
$2.69B
Share price x shares outstanding.
Enterprise value
$4.65B
Market cap + total debt - cash - short-term investments.
P/E
13.6x
Market cap / net income. Only when net income is positive.
P/S
0.76x
Market cap / revenue.
P/B
1.24x
Market cap / shareholders' equity. Only when equity is positive.
P/FCF
26.9x
Market cap / free cash flow. Only when free cash flow is positive.
P/OCF
9.31x
Market cap / cash from operations, when positive.
EV/Sales
1.31x
Enterprise value / revenue.
EV/FCF
46.5x
Enterprise value / free cash flow, when both are positive.
FCF yield
3.7%
Free cash flow / market cap.
Earnings yield
7.3%
Net income / market cap (the inverse of P/E).
Dividend yield
1.9%
Dividends paid over the period / market cap.
Shareholder yield
3.7%
(Dividends paid + share buybacks) / market cap.
What was FULLER H B CO's revenue in fiscal 2025?
FULLER H B CO reported revenue of $3.47B for fiscal 2025, 2.7% lower than the year before.
Was FULLER H B CO profitable in fiscal 2025?
Yes. Net income was $152.0M, a net margin of 4.4%.
How much free cash flow did FULLER H B CO generate in fiscal 2025?
Cash from operations of $263.5M minus capital expenditures of $142.3M left free cash flow of $121.2M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.